Crinetics Pharmaceuticals (CRNX) Gross Profit (2025 - 2026)
Crinetics Pharmaceuticals (CRNX) posted quarterly Gross Profit of $10.5 million for Q1 2026, up 2818.01% year-over-year from $361000.0 in Q1 2025, and up 2818.01% quarter-over-quarter from $361000.0 in Q1 2025.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Gross Profit (2025 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Gross Profit history runs 2 years deep, the most recent figure standing at $10.5 million for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.96 Mn |
| Mar 31, 2026 | 10.53 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 361,000.00 |